Erectile Dysfunction May Be Marker for Prediabetes, Diabetes
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 1, 2023 -- Erectile dysfunction (ED) may be a marker for undiagnosed prediabetes/type 2 diabetes (T2D), according to a study published online July 25 in Preventive Medicine.
Jane Tucker, from Saint Louis University in Missouri, and colleagues examined whether patients with ED have an increased risk for prediabetes and/or T2D and assessed the duration between ED and prediabetes/T2D diagnosis in a retrospective cohort study. The analysis included deidentified medical record data from patients aged 18 to 40 years old.
The researchers found that after controlling for confounding, ED was associated with an increased risk for prediabetes/T2D (relative risk [RR], 1.34). Similar results were seen for ED and T2D alone (RR, 1.38). ED and prediabetes/T2D were diagnosed on the same day for 30 percent of patients, while 75 percent were diagnosed with prediabetes/T2D within a year of ED.
“ED may offer the opportunity for earlier detection and diagnoses of T2D, particularly in younger men,” conclude the authors. “Younger patients presenting with ED should be screened for hyperglycemia.”
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world...
Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening
MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published...
ADA: Bisphenol A Linked to Reduced Peripheral Insulin Sensitivity
THURSDAY, June 27, 2024 -- Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.